Ebopiprant HCl

Ebopiprant (OBE-022) is an orally active, selective prostaglandin F2α receptor antagonist developed for preterm labor research. It demonstrates potent tocolytic efficacy in ex vivo human tissue and in vivo animal models, offering a favorable safety profile by avoiding fetal side effects associated with non-selective COX inhibitors like indomethacin.